Ablation of Bscl2/Seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
| dc.contributor.author | Mcilroy, George D | |
| dc.contributor.author | Mitchell, Sharon E | |
| dc.contributor.author | Han, Weiping | |
| dc.contributor.author | Delibegović, Mirela | |
| dc.contributor.author | Rochford, Justin J | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Cardiovascular and Diabetes Centre | en |
| dc.contributor.institution | University of Aberdeen.Rowett Institute | en |
| dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2020-01-23T16:10:01Z | |
| dc.date.available | 2020-01-23T16:10:01Z | |
| dc.date.issued | 2020-01-17 | |
| dc.description | Funding Work was supported by the Medical Research Council (GDM/JJR; MR/L002620/1, MC/PC/15077), the Biotechnology and Biological Sciences Research Council (JJR; BB/K017772/1), Diabetes UK (GDM/JJR; 18/0005884), the British Heart Foundation (MD;PG/14/43/30889) and the Wellcome Trust and the University of Aberdeen ISSF Fund (GDM; ISSF Fellowship Support Fund). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 2410511 | |
| dc.identifier | 152454206 | |
| dc.identifier | 56e2f1a0-b1dc-4fbe-a6d2-22722518189d | |
| dc.identifier | 31848133 | |
| dc.identifier | 31848133 | |
| dc.identifier | 85078504837 | |
| dc.identifier | 000512345300007 | |
| dc.identifier.citation | Mcilroy, G D, Mitchell, S E, Han, W, Delibegović, M & Rochford, J J 2020, 'Ablation of Bscl2/Seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy', Disease Models & Mechanisms, vol. 13, no. 1, dmm042655. https://doi.org/10.1242/dmm.042655 | en |
| dc.identifier.doi | 10.1242/dmm.042655 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1754-8403 | |
| dc.identifier.other | ORCID: /0000-0002-5020-4939/work/79062189 | |
| dc.identifier.other | ORCID: /0000-0003-4230-4355/work/102133116 | |
| dc.identifier.other | ORCID: /0000-0001-6193-3152/work/160847571 | |
| dc.identifier.uri | https://hdl.handle.net/2164/13584 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85078504837&partnerID=8YFLogxK | en |
| dc.identifier.vol | 13 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Disease Models & Mechanisms | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Lipodystrophy | en |
| dc.subject | BSCL2CGL | en |
| dc.subject | Hepatocyte | en |
| dc.subject | AAV | en |
| dc.subject | CRISPR | en |
| dc.subject | BSCL2 | en |
| dc.subject | CGL | en |
| dc.subject | INSULIN SENSITIVITY | en |
| dc.subject | SEIPIN | en |
| dc.subject | LIPOLYSIS | en |
| dc.subject | RESISTANCE | en |
| dc.subject | MICE | en |
| dc.subject | KNOCKOUT | en |
| dc.subject | R Medicine | en |
| dc.subject | Immunology and Microbiology (miscellaneous) | en |
| dc.subject | General Biochemistry,Genetics and Molecular Biology | en |
| dc.subject | Neuroscience (miscellaneous) | en |
| dc.subject | Medicine (miscellaneous) | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/L002620/1 | en |
| dc.subject | MC/PC/15077 | en |
| dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
| dc.subject | BB/K017772/1 | en |
| dc.subject | British Heart Foundation | en |
| dc.subject | MD;PG/14/43/30889 | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | ISSF Fellowship Support Fund | en |
| dc.subject.lcc | R | en |
| dc.title | Ablation of Bscl2/Seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Mcilroy_etal_dmm042655_ablation_VOR.pdf
- Size:
- 2.3 MB
- Format:
- Adobe Portable Document Format
